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Abstract—Glucose is the primary source of energy for the 
cells of the human body. Keeping the blood glucose level 
between certain thresholds is essential for the proper energy 
transport. Insulin plays a key role in maintaining the glucose 
homeostasis for the human body. Because of its great 
importance, many models were published on either to describe 
the glucose-insulin interaction in case of patients under 
Intensive Care Unit (ICU), or to model Type 1 Diabetes 
Mellitus (T1DM). Currently for most of the models linear 
control concepts are used in order to design an appropriate 
controller. The aim of the current paper is to investigate 
applicability of nonlinear control theory providing exact 
mathematical background in the control problem of glucose-
insulin interaction. Both ICU and T1DM cases are analyzed on 
well-known models with different complexity: the model of [1] 
in case of ICU, and [2] in case of T1DM. Our aim is to hide the 
nonlinearity of the models by transforming the signal coming 
from a linear controller so that the response of the model would 
mimic the behavior of a linear system, desirably the one 
acquired through steady-state linearization; hence extending 
the validity of linear controllers. The asymptotic tracking 
problem needs the value of the state variables; therefore, 
Kalman-filter extended for nonlinear systems is applied. The 
capabilities of this approach are examined through classical 
control algorithms and input data recorded in actual clinical 
environment. 
I. INTRODUCTION 
HE blood glucose level is maintained through a 
complex endocrine system of the human body, which is 
responsible among others for energy transport. The normal 
blood glucose concentration level in the human body varies 
in a narrow range (70 - 110 mg/dL). If the human body is 
unable to control the normal glucose-insulin interaction 
diabetes mellitus is diagnosed. The consequences of diabetes 
are mostly long-term; among others increasing the risk of 
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neuropathy, retinopathy and cardiovascular diseases [3]. 
Due to its frightening increase the World Health 
Organization (WHO), warns that diabetes could be the 
“disease of the future” [4]. 
From an engineering point of view, the treatment of 
diabetes mellitus can be represented by an outer control 
loop, to replace the partially or totally deficient blood 
glucose control system of the human body. The quest for 
artificial pancreas can be structured in three different tasks 
[5]-[6]: continuous glucose sensor for measurements, insulin 
pump for infusion and control algorithm. 
To design an appropriate control, an adequate model is 
necessary. In the last few decades different mathematical 
models of the human blood glucose system appeared. A 
brief overview can be found in [7]. Nowadays, the most 
complex models used in T1DM research are [2], [8]-[10]. 
On the other hand, blood glucose control is also very 
important in intensive care treatment. Critically ill patients 
admitted to the ICU often display hyperglycaemia and 
insulin resistance associated with adverse outcomes, which 
can result in increased morbidity and mortality [11]. Tight 
glycaemic control (TGC) can reduce these adverse outcomes 
[12]-[13], as well as reducing economic costs [14]. Hence, 
TGC using model-based methods has become an active 
research field [15]. The best known model is the minimal 
model of Bergman [16]. However, the model’s simplicity is 
a disadvantage. Hence, different models were derived from 
the minimal model, trying to generalize / extend the validity 
for the ICU case [1], [17]-[18]. 
The nonlinearity in each of the above mentioned models, 
ICU or T1DM represent specific control aspects, but the 
applied control strategies are usually developed for their 
linearized (i.e. working point based) versions. 
Generalization of this problem can be realized using 
nonlinear control theory [19]. The current paper investigates 
this aspect in terms of differential geometric approach. Both 
ICU and T1DM cases are analyzed on well-known, but 
different complexity models: the model presented by Lotz et 
al [1] in case of ICU, and the model presented by Magni et 
al [2] in case of T1DM. 
Our aim is to hide the nonlinearity of the physiological 
model by transforming the control input provided by a linear 
controller so that the response of the model would mimic the 
behavior of a linear system. Hence, the validity of linear 
controllers can be extended from the neighborhood of a 
working point to a larger subset of the state-space bounded 
by specific constraints. This approach might not increase the 
performance of the controllers to a great extent, but the 
reliability of tight glucose control can directly effect the 
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quality of life of a type-1 diabetes or ICU patient. Our goal 
is a control algorithm whose stability and performance can 
be guaranteed and mathematically proven according to 
adequate medical specifications. 
The paper is structured as follows. First, the target of our 
investigation, the two models (ICU [1] and T1DM [2]) are 
presented. This is followed by a brief summary of the 
applied nonlinear control theory methods and aspects of 
Kalman-filtering. Section IV presents the obtained results, 
while Section V concludes the paper and formulates further 
research directions. 
II. MODELS 
A. The considered ICU model 
The clinically validated model of [1] is basically a 
generalization of the Bergman minimal model [16]. It better 
captures insulin losses to the liver and kidneys, and 
saturation dynamics through the use of Michaelis-Menten 
functions. The parameters of the model have been identified 
to a wide range of patients. Below, we summarize the model 
equations. Numerical values can be found in [1]. 
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The states of the system are: 
 G is the deviation of plasma glucose concentration 
(mmol/L) from equilibrium level (GE); 
 I represent the concentration of plasma insulin 
resulting from external input (mU/L); 
 Q is the concentration of insulin bounded to 
interstitial sites (mU/L); 
Regarding the inputs of the system, P represents the 
glucose input through enteral feeding (mmol/min), while uex 
is the intravenously administered external insulin (mU/min). 
Other notations appeared represent parameters: pG is the 
endogenous glucose clearance (min-1); SI is the insulin 
sensitivity (L/mU/min); αG is the insulin dependent glucose 
clearance/insulin effect (L/mU); EGP is the endogenous 
glucose production (mmol/min); VG, VQ and VP are the 
glucose distribution volume, interstitial fluid volume and the 
plasma volume with fast exchanging tissues (L); xL is the 
fraction of hepatic extraction (-); nK, nL are the kidney and 
liver clearance rates of insulin from plasma (min-1); nI is the 
diffusion constant of insulin between compartments (L/min); 
nC is the cellular insulin clearance rate from interstitium 
(min-1); αI is the plasma insulin disappearance rate (L/mU); 
uen is the constant endogenous insulin production (mU/min). 
B. The considered T1DM model 
The T1DM model of [2] dates back to the complex 
glucose-insulin model of [8] and represents an in-silico 
glucose metabolism model with compartments to describe 
subcutaneous insulin delivery and subcutaneous continuous 
glucose monitoring, as well as an intestinal glucose 
absorption model integrated into its structure. The model has 
a modular build, but here it will be presented as a single 
system. Numerical values can be found in [2] and [8]. 
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The system has 10 state variables: 
 GM – subcutaneous glucose concentration (mg/dL); 
 Gp – glucose in plasma and rapidly equilibrating 
tissues (mg/kg); 
 Gt – glucose in slowly equilibrating tissues (mg/kg); 
 X – insulin in interstitial fluid (pmol/L); 
 Id, I1 – state variables for delayed insulin signal 
(pmol/L); 
 Ip – insulin mass in plasma (pmol/kg); 
 Il – insulin mass in liver (pmol/kg); 
 S2 – monomeric insulin in the subcutaneous tissue 
(pmol/kg); 
 S1 – polymeric insulin in the subcutaneous tissue 
(pmol/kg). 
The inputs of the system are the u injected insulin flow 
(pmol/min) and Ra the glucose rate of appearance in plasma 
(mg/min). 
The parameters of the model are the followings: VG is the 
distribution volume of glucose (dL/kg); Uii is the insulin-
independent glucose utilization (mg/kg/min); k1, k2 are rate 
parameters of the glucose subsystem (min-1); ke1 represents 
renal glomerular filtration rate (min-1); ke2 renal threshold 
(mg/kg); Vi is the insulin distribution volume (L/kg); m1, m2, 
m3, m4 are rate parameters of the insulin subsystem (min
-1); 
BW is the body weight (kg); kp1 is the extrapolated 
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endogenous glucose production at zero glucose and insulin 
(mg/kg/min); kp2 is the liver glucose effectiveness (min
-1); 
kp3 is the indicator of effect of a delayed insulin signal 
(mg·L/kg/min/pmol); ki is the model parameter of delayed 
insulin signal (min-1); Ib is the basal level of plasma insulin 
concentration (pmol/L); p2U is the rate constant of insulin 
action (min-1); Km0, Kmx, Vm0 and Vmx are model parameters 
for insulin-dependent glucose utilization (-); kd is 
degradation constant (-); ka1, ka2 are absorption constants (-); 
ks.c. is rate constant for the subcutaneous glucose 
compartment (-). 
A big advantage of the model is the integrated, three-
compartment intestinal glucose absorption model, which 
describes glucose transit through the stomach and intestine 
to the plasma in case of enteral feeding. Detailed description 
of this system can be found in [8]. 
Although the glucose absorption model is used in the 
simulations to acquire glucose absorption profile, it is not 
regarded as part of the model. Te glucose rate of appearance 
(Ra) is either considered as disturbance or a known time-
varying parameter. 
III. METHODS 
A. Exact linearization via feedback 
The concept of exact linearization of a nonlinear system 
via nonlinear state feedback control was introduced in [19]. 
Consider a SISO nonlinear system in the form: 
         





f and g are smooth nR -valued mappings and h is a 
smooth real-valued mapping defined on an open set nRU  . 
This system is said to have a relative degree r on an open 
and dense subset V of the open set U if for all UVx 0 : 
   0xhLL kfg  for all x in a neighborhood of 0x  and 
all k < r-1 
   001  xhLL rfg  
where   txhL f  is the Lie-derivate of h(x(t)) along f. Let us 
assume that the nonlinear system (3) has relative degree 
)dim(xnr   at x0. For the coordinate mapping: 
   
   















  (4) 
it is always possible to find n-r more functions 
   x,,x nr  1  such that the mapping: 
        Tn xxxxz  21  (5) 
has a nonsingular Jacobian matrix at x0 and therefore 
qualifies as local diffeomorphism in a neighborhood of x0. 
Let us introduce the following notations: 
    zhLLza rfg 11    (6/a) 
    zhLzb rf 1   (6/b) 
       uzLzLu,zq igifi 11    , r+1 ≤ i ≤ n;  (6/c) 
 Trzz 1  (6/d) 
 Tnr zz 1  (6/e) 
The state-space description of the system in the new 
coordinates will be as follows: 



































Let us use the following control law on this system: 
            tvtxbtxatu 
1  (8) 
This way, as long as the subsystem  u,,q   (with 
 t having the trajectory of  tR  for the control law) is 
uniformly asymptotically stable in Ljapunov-sense, then the 
system will act as a series of r integrators while the state 
variables x are within the open and dense subset V where the 
local coordinate mappings remain a local diffeomorphism 
for every UVx 0 . Note that the system must not 
necessary be reachable, since  u,,q  might be 
independent from the input. 
B. Asymptotic Output Tracking 
Instead of forcing the output of a nonlinear system to 
follow exactly the output of a prescribed reference linear 
system, it is more realistic to produce an output that, 
irrespectively of the initial state of the system converges 
asymptotically to the output of a reference linear system, 
which is called asymptotic output tracking [19]. Let us have 










Choose this system with a relative degree equal to or 
higher than the relative degree of the nonlinear system: 
    tCAty iiR  , 10  mi , rm   (10/a) 
     BwCAtCAty mmmR
1   (10/b) 
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If we have an appropriately chosen r-th order 
asymptotically stable linear system with transfer function: 



























  (11) 
then using the following control law we can force the 
nonlinear system to have the same output for the input w as 
the series of the linear system (9) and (11): 
 
  
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If the relative degree of the linear system (9) is higher 
than the relative degree of the nonlinear system, then 
  01  tBwCAb rr . 
C. Kalman-filter 
Both exact linearization and asymptotic output tracking 
need the values of the state variables. In practice however 
the only measured quantity is either the intravenous or 
subcutaneous glucose concentration. The sensors used in 
these measurements usually have relatively high noise and a 
sampling time of 3-5 minutes, therefore a Kalman-filter is 
needed to provide adequate state-estimation. Kalman-
filtering has a wide literature. In our case, the following 
algorithm was used [20]:  
















01  (13/c) 
1111   k,v
T
kkkk RAAM   (13/d) 
  1 k,zTkkkTkkk RCMCCMG  (13/e) 
kkkkk MCGM   (13/f) 
  0,xgyGxx̂ kkkkk   (13/g) 







1  (14) 
and the following notations are used: 
 vk is the noise of the state variables (xk); 
 zk is the noise of the output signal; 
  0x  is the initial condition for the state variables; 
    00 xxE   and        000 000  TxxxxE ; 
   0kvE  and   l,kk,vTlk RvvE  , 0k,vR ; 
   0kzE  and   l,kk,zTlk RzzE  , 0k,zR ; 
IV. RESULTS 
A. Asymptotic tracking of the ICU model 
The relative degree of the ICU model is maximal, 
therefore the coordinate transformation for both exact 
linearization and asymptotic output tracking are 
unequivocally determined, and the system has no zero 
dynamics. The system has a single output (G), and only the 
external insulin input (uex) can be controlled, therefore the 
system can be considered as a SISO system. The other input 
(P) can be regarded as disturbance, but its value is known. 
Considering the connections between each compartment the 
system can be divided into a subsystem described by 
differential equations (1/b) and (1/c) with Q as its output, 
and a second one described by a single differential equation 
(1/a). Hence, determining control law for exact linearization 
or asymptotic output tracking separately is possible. Real 
advantage of this approach is when working with more 
complex models [8]-[10]. 
The first subsystem is transformed into a series of 
integrators through exact linearization. The local coordinate 
transformation determined by the Lie-derivates is a local 
diffeomorphism regardless of the state variables. 
 






































The control law (8) is applicable as long as 3
1 xI 
 . 
The second control law of the controller does not realize 
exact linearization but asymptotic output tracking, and is 
working with the following nonlinear system: 
          
 
   

























The local coordinate-transformation for this system is a 
local diffeomorphism as long as: 





























The properties of the second control loop are determined 
in a way that the nonlinear system would track the output of 
its own steady-state linearization with appropriately fast 
error dynamics. The structure of the complete controller is 
shown in Fig. 1. 
To provide the values of state variables for the control 
laws, the (13/a-g) extended Kalman-filter algorithm has 
been used. The discrete-time nonlinear model (14) has been 
created with fourth-order Runge–Kutta method. 
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Figure 1.  Structure of the tracking controller for the ICU model [1]. 
Computing (13/b) has been done with an iterative 
algorithm as well. The output signal was measured with 5 
minute sampling time. The performance of the Kalman-filter 
is presented in Fig. 2. 
The output of the nonlinear system with and without 
using the presented control laws is compared with the series 
of linear systems determined for the tracking error and the 
linear system that needs to be followed in Fig. 3. 
 
 
Figure 2.  Comparison of the steady-state linearization of the ICU model 
with the output resulting from asymptotic output tracking and with the 
output of the original model. 
 
Figure 3.  The real and estimated values of state variables acquired from 
the simulated output samples with added Gaussian measurement noise. 
For the steady-state linearization of model (1) a classical 
PID controller was implemented to show the advantages of 
the applied methodology even in case of a low level 
controller (Fig. 4). It can be seen that quality parameters 
(settling time and overshoot) gave better results in case of 
asymptotic tracking then in case of the nonlinear model. The 
structure of the controller was first determined in continuous 
time domain, and then transformed into a discrete-time: 






















pPID  (19) 
       sWLzzD PIDPID 111    (20) 
B. Asymptotic output tracking of a T1DM model 
The model presented in (2) is not easy to be handled with 
methods based on differential geometry, because it has a 
relatively high number of state variables and it has a relative 
degree that is almost the half of that value. Moreover, some 
modifications need to be done in order to have smooth 
mappings in the system. Considering the connections 




Figure 4.  Glucose absorption profile used in the simulations (top) and the 
performance of a PID controller with and without asymptotic output 
tracking (bottom). 
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Figure 5.  Structure of the tracking controller for the T1DM model [2]. 
The first subsystem has 4 states, with injected insulin flow 
as input, and Ip as output. It is basically linear with a relative 
degree of 2. 
           
       
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The second subsystem has 5 states, with Ip as input,and Gp 
as output. Its relative degree is 3. 
            
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          
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The last subsystem is a first order linear system with Gp as 
input and GM as output. 








..   (23) 
We can perform exact linearization on the first subsystem 
using the following local coordinate transformation: 





























aa  (24) 
 x  is a local diffeomorphism in all points of the whole 
state-space, since: 




The zero dynamics of the system are uniformly 
asymptotically stable in Ljapunov-sense. 





















After applying the proper control law in the form (8), it is 
essential to transform the resulting series of integrators into 
an asymptotically stable system with poles p1 and p2 
guaranteeing that the zero dynamics of the next subsystem 








  (27) 
Consequently, the structure of the current control problem 
can be delimited in two loops (Fig. 5): the first responsible 
for the exact linearization via feedback and Kalman-filtering, 
while the second for the asymptotic output tracking. 
In the second loop, the asymptotic output tracking will be 
realized on the series of (27) and the second subsystem. The 
relative degree of this system is 5; therefore, two 5th order 
linear systems are needed: W1(s) the followed linear system 
(9), and W2(s) the tracking dynamics (11). Due to the 
subsystems’ nonlinearities, the coordinate transformation and 
the control law have limited applicability with several 
inequality-constrains to be taken into consideration, and 
singular points to be avoided. Since the steady-state 
linearization of the series of the first two subsystems results 
in a 9th order linear system, only one extra pole should be 
added to complete W1(s) and W2(s). 
The difference between the steady-state linear system, the 
model, and the model combined with the control law 
introduced above is shown in Fig. 6. Although the 
asymptotic output tracking response converges to the 
linearized model, slight deviations occur when there is a 
sudden change in the meal absorption input. This is caused 
by the fact that the relative degree of the model for the 
absorbed glucose input (Ra) is less than the relative degree 
for the injected insulin input. We should also mention that 
for the original system the deviation of the output from its 
basal value (250 mg/dL) is displayed. 
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Figure 6.  Comparison of the steady-state linearization of model (2) with 
asymptotic output tracking and with the deviation of the output for the 
original model from its basal value (250 mg/dL). 
 
Figure 7.  The real and estimated values of three state variables (Gp, Ip and 
X) acquired from the simulated output samples with added Gaussian 
measurement noise (bottom right). 
 
Figure 8.  Glucose absorption profile used in the simulations (top) and the 
performance of a PID controller with and without asymptotic output 
tracking (bottom). 
For the estimation of state variables the extended Kalman-
filter algorithm (13/a-g) was used on the simulated output, to 
which a zero-mean white Gaussian noise was added with 51 
mg2/dL2 variance, similarly to the simulations presented in 
[21]. The sampling time was 5 minutes. The performance of 
the Kalman-filter is displayed on Fig. 7. It can be seen that 
the output is well filtered even with a relatively big 
measurement noise. 
For the steady-state linearization of model (2) a classical 
PID controller was implemented to show the advantages of 
the applied methodology even in case of a low level 
controller. The structure of the controller was first 
determined in continuous time domain, and then transformed 
into discrete-time with the same 5 minute sampling frequency 
that was used in the sensor model: 


































  (28) 
       sWLzzD PIDPID 111    (29) 
The performance of the controller on the model has been 
compared with the case when the control law for asymptotic 
tracking is used (Fig. 8). In this case, the glucose rate of 
appearance (Ra) is considered as a known time-varying 
parameter. 
It can be seen that the designed nonlinear approach is able 
to keep the glucose level inside the defined 80-120 mg/dL 
interval. For T1DM case simulations a clinically recorded 
feeding profile has been used (Fig. 8), regarding 1 week’s 
real data of a 17 year old boy. 
V. CONCLUSION 
The aim of the current paper was to apply asymptotic 
tracking for the highly nonlinear model [2]. We managed to 
hide the nonlinearity of the physiological model by 
transforming the control input provided by a linear controller 
so that the response of the model would mimic the behavior 
of a linear system. In addition, a Kalman-filter extended for 
nonlinear systems was designed to estimate the values of the 
state variables. 
It can be concluded from the simulation results that the 
methods presented have the potential to extend the validity 
of linear controllers. However, due to its limitations, several 
practical issues should be considered in the future, like: state 
estimation particularities; questions of sampling frequency 
smaller than 5 minutes; parameter sensitivity. 
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